GMP Certified / Paclitaxel Injection 100mg/16.7ml

Product Details
Customization: Available
Quality Standard: USP, Bp
Factory Certified: GMP
Still deciding? Get samples of US$ 0.01/Piece
Request Sample
Manufacturer/Factory, Trading Company, Group Corporation
Gold Member Since 2018

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

Importers and Exporters
The supplier has import and export rights
to see all verified strength labels (7)
  • GMP Certified / Paclitaxel Injection 100mg/16.7ml
  • GMP Certified / Paclitaxel Injection 100mg/16.7ml
  • GMP Certified / Paclitaxel Injection 100mg/16.7ml
  • GMP Certified / Paclitaxel Injection 100mg/16.7ml
  • GMP Certified / Paclitaxel Injection 100mg/16.7ml
  • GMP Certified / Paclitaxel Injection 100mg/16.7ml
Find Similar Products

Basic Info.

Model NO.
injection
Ctd Status
Available
Transport Package
Sea Transportation
Specification
100mg/16.7ml
Trademark
Sinolead
Origin
China
Production Capacity
100, 000, 000 Per Year

Product Description

Product Description
 
          Generic name Paclitaxel Injection
             Strength 100mg/16.7ml
             Standard BP
             Shelf life 2 years
         Packing form 1 vial/box

Value-added services:
 Packaging design by our team
 
Registration service by our team

 Registration dossier available by our team
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------


Product name:
Paclitaxel Injection 100mg/16.7ml

Character:
This product is colorless or yellowish viscous liquid.

Indications:
First-line and subsequent treatment of advanced ovarian cancer.
Adjuvant therapy after standard doxorubicin-containing chemotherapy in patients with lymph node positive breast cancer.
Patients with metastatic breast cancer who have failed combination chemotherapy or have recurred within six months of adjuvant chemotherapy.
First-line treatment for patients with non-small cell lung cancer.
Second-line treatment of AIDS-associated karnosarcoma.


Pharmacology and toxicology:
Taxol (paclitaxel) injection Paclitaxel is a novel anti-microtubule agent. Stabilizing the microtubules by promoting the combination of tubulin dimers and preventing their depolymerization inhibits the normal dynamic recombination of the micropipe network, which is essential for intermitotic and mitotic cell function. In addition, paclitaxel can cause abnormal arrangement of microtubule "bundles" throughout the cell cycle and mitosis when multiple stellates are produced, affecting the division of tumor cells.
The carcinogenicity of taxol (paclitaxel) has not been studied. The mutagenicity of Taxitin has been demonstrated in vitro (human lymphocyte chromosome aberration) and in vivo (mouse micronucleus) test systems in mammals, however, Taxitin does not induce mutation in Ames test or CHO/HGPRT gene mutagenicity test.


Storage:
Store under 25ºC away from light.
GMP Certified / Paclitaxel Injection 100mg/16.7ml
GMP Certified / Paclitaxel Injection 100mg/16.7mlGMP Certified / Paclitaxel Injection 100mg/16.7mlGMP Certified / Paclitaxel Injection 100mg/16.7ml
GMP Certified / Paclitaxel Injection 100mg/16.7mlGMP Certified / Paclitaxel Injection 100mg/16.7mlGMP Certified / Paclitaxel Injection 100mg/16.7mlGMP Certified / Paclitaxel Injection 100mg/16.7ml



 

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier